Cargando…
SOX17 Inhibits Tumor Metastasis Via Wnt Signaling In Endometrial Cancer
BACKGROUND: Endometrial cancer (EC) is the most common gynecological malignancy with high incidence of metastasis, while the mechanism of metastasis in EC is not clear. METHODS: Immunohistochemistry and real-time PCR assays were used to assess expression of SOX17 in paraffin-embedded tissues from EC...
Autores principales: | Zhou, Weiqiang, Wang, Kai, Wang, Jingyun, Qu, Junjie, Du, Guiqiang, Zhang, Yongli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789416/ https://www.ncbi.nlm.nih.gov/pubmed/31632077 http://dx.doi.org/10.2147/OTT.S220536 |
Ejemplares similares
-
EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt/β-catenin signaling in endometrial carcinoma
por: Yang, Tingting, et al.
Publicado: (2016) -
SOX17 is a tumor suppressor in endometrial cancer
por: Zhang, Yongli, et al.
Publicado: (2016) -
TRIB3 suppresses proliferation and invasion and promotes apoptosis of endometrial cancer cells by regulating the AKT signaling pathway
por: Qu, Junjie, et al.
Publicado: (2019) -
SOX17 increases the cisplatin sensitivity of an endometrial cancer cell line
por: Zhang, Yongli, et al.
Publicado: (2016) -
Sox17 Promotes Oligodendrocyte Regeneration by Dual Modulation of Hedgehog and Wnt Signaling
por: Ming, Xiaotian, et al.
Publicado: (2020)